Evaluating the Clinical Outcomes of Using Pro-Yellow Laser for Steroid-Induced Rosacea: A Prospective Clinical Study

Authors

  • Ethar Falah Hasan Department of General Medicine, College of Medicine Al-Nahrain University, Baghdad, Iraq https://orcid.org/0000-0003-0736-8361
  • Mustafa Hazim Ahmed Dermatology Department, Al-Kindy Teaching Hospital, Baghdad, Iraq
  • Noor Mohammed Hraiga Dermatology Department, Al-Kindy Teaching Hospital, Baghdad, Iraq

DOI:

https://doi.org/10.54133/ajms.v9i2.2445

Keywords:

Laser 577 nm, Pro-yellow laser, Rosacea, Researcher score

Abstract

Background: Erythematotelangiectatic rosacea, face erythema, and facial telangiectasias have all been treated with different types of lasers. It has not yet been documented how well a 577-nm pro-yellow laser treats each of these disorders. Objectives: To assess the efficacy and safety of the Pro-yellow laser 577 nm in the management of rosacea. Methods: Six months, from January to July 2024, were devoted to a clinical experiment. Sixty individuals, ranging in age from twenty to sixty, were evaluated by two dermatologists for the presence of either papulopustular or erythematotelangiectatic rosacea. Two groups were formed from them: group A, which included 30 patients receiving a combination treatment that also included laser therapy, and group B, which also included 30 patients receiving a combination therapy treatment but without laser therapy. The clinician utilized the researcher's score, which is an evaluation technique with three scales: region, telangiectasia, and erythema assessment. Results: After three months, patients in group A showed a considerably greater average increase in total researcher's score, erythema, area, and telangiectasia compared to group B. After a month of treatment, group A had a greater percentage of significant improvements than group B. Group A showed a substantially greater rate of outstanding development compared to group B after three months. Conclusions: With little adverse effects, the pro-yellow laser 577 nm is a novel and efficient treatment for telangiectasia and persistent erythema in rosacea with long-lasting effect and rapid improvement of symptoms combined with conventional treatment.

Downloads

Download data is not yet available.

References

Türkmen D, Türkoğlu G. Demodex infestation in patients with rosacea. Turkiye Parazitolojii Dergisi. 2019;43. doi: 10.4274/tpd.galenos.2019.6456. DOI: https://doi.org/10.4274/tpd.galenos.2019.6456

Rodrigues-Braz D, Zhao M, Yesilirmak N, Aractingi S, Behar-Cohen F, Bourges JL. Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models. Mol Vis. 2021;27:323-353. PMID: 34035646.

Van Zuuren EJ. Rosacea. N Engl J Med. 2017;377(18):1754-1764. doi: 10.1056/NEJMcp1506630. DOI: https://doi.org/10.1056/NEJMcp1506630

Geng RSQ, Bourkas AN, Mufti A, Sibbald RG. Rosacea: Pathogenesis and therapeutic correlates. J Cutan Med Surg. 2024;28(2):178-819. doi: 10.1177/12034754241229365. DOI: https://doi.org/10.1177/12034754241229365

Chen C, Wang P, Zhang L, Liu X, Zhang H, Cao Y, et al. Exploring the pathogenesis and mechanism-targeted treatments of Rosacea: Previous understanding and updates. Biomedicines. 2023;11(8). doi: 10.3390/biomedicines11082153. DOI: https://doi.org/10.3390/biomedicines11082153

Baldwin HE, Harper J, Baradaran S, Patel V. Erythema of rosacea affects health-related quality of life: results of a survey conducted in collaboration with the National Rosacea Society. Dermatol Ther. 2019;9:725-734. doi: 10.1007/s13555-019-00322-5. DOI: https://doi.org/10.1007/s13555-019-00322-5

Thiboutot D, Anderson R, Cook-Bolden F, Draelos Z, Gallo RL, Granstein RD, et al. Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2020;82(6):1501-1510. doi: 10.1016/j.jaad.2020.01.077. DOI: https://doi.org/10.1016/j.jaad.2020.01.077

Sharma A, Kroumpouzos G, Kassir M, Galadari H, Goren A, Grabbe S, et al. Rosacea management: a comprehensive review. J Cosmet Dermatol. 2022;21(5):1895-1904. doi: 10.1111/jocd.14816. DOI: https://doi.org/10.1111/jocd.14816

Hampton P, Berth‐Jones J, Duarte Williamson C, Hay R, Leslie T, Porter I, et al. British Association of Dermatologists guidelines for the management of people with rosacea 2021. Br J Dermatol. 2021;185(4):725-735. doi: 10.1111/bjd.20485. DOI: https://doi.org/10.1111/bjd.20485

Paiva-Santos AC, Gonçalves T, Peixoto D, Pires PC, Velsankar K, Jha NK, et al. Rosacea topical treatment and care: from traditional to new drug delivery systems. Molecular Pharmaceutics. 2023;20(8):3804-28. doi: 10.1021/acs.molpharmaceut.3c00324. DOI: https://doi.org/10.1021/acs.molpharmaceut.3c00324

Albahadili M, Ismael SM, Al-Samarraee MF. Is it Possible to Manage Appendicular Mass Without Surgery?. Al-Rafidain Journal of Medical Sciences. 2025 Oct 3;9(2):46-50. DOI: https://doi.org/10.54133/ajms.v9i2.2322

Temiz SA, Durmaz K, Işık B, Ataseven A, Dursun R. The effect of 577‐nm pro‐yellow laser on demodex density in patients with rosacea. J Cosmet Dermatol. 2022;21(1):242-246. doi: 10.1111/jocd.14085. DOI: https://doi.org/10.1111/jocd.14085

Yepuri V, Patil AD, Fritz K, Salavastru C, Kroumpouzos G, Nisticò SP, et al. Light-based devices for the treatment of facial erythema and telangiectasia. Dermatol Ther (Heidelb). 2021;11(6):1879-1887. doi: 10.1007/s13555-021-00607-8. DOI: https://doi.org/10.1007/s13555-021-00607-8

Altunisik N, Turkmen D, Sener S. Evaluation of the effect of 577-nm pro-yellow laser on demodex intensity. J Cosmet Laser Ther. 2021;23(7-8):221-224. doi: 10.1080/14764172.2022.2075898. DOI: https://doi.org/10.1080/14764172.2022.2075898

Mohamed EEM, Mohamed Tawfik K, Hassan Ahmad W. Successful treatment of facial vascular skin diseases with a 577‐nm pro‐yellow laser. J Cosmet Dermatol. 2019;18(6):1675-679. doi: 10.1111/jocd.12963. DOI: https://doi.org/10.1111/jocd.12963

Yang R, Liu C, Liu W, Luo J, Cheng S, Mu X. Botulinum toxin A alleviates persistent erythema and flushing in patients with erythema telangiectasia rosacea. Dermatol Ther. 2022;12(10):2285-2294. doi: 10.1007/s13555-022-00784-0. DOI: https://doi.org/10.1007/s13555-022-00784-0

Ataseven A, Temiz SA, Özer İ. An investigation of the effectiveness of the 577-nm pro-yellow laser in patients with vascular disorders. Eur J Ther. 2023;29(1). doi: 10.58600/eurjther-346. DOI: https://doi.org/10.58600/eurjther-346

Cios A, Ciepielak M, Szymański Ł, Lewicka A, Cierniak S, Stankiewicz W, et al. Effect of different wavelengths of laser irradiation on the skin cells. Int J Mol Sci. 2021;22(5):2437. doi: 10.3390/ijms22052437. DOI: https://doi.org/10.3390/ijms22052437

Kapicioglu Y, Sarac G, Cenk H. Treatment of erythematotelangiectatic rosacea, facial erythema, and facial telangiectasia with a 577-nm pro-yellow laser: a case series. Lasers Med Sci. 2019;34:93-98. doi: 10.1007/s10103-018-2606-6. DOI: https://doi.org/10.1007/s10103-018-2606-6

Aksoy Sarac G, Onder M. Evaluation of the efficacy of pro‐yellow laser in the management of vascular skin disorders. J Cosmet Dermatol. 2022;21(3). doi: 10.1111/jocd.14162. DOI: https://doi.org/10.1111/jocd.14162

Mohamed E, Younes AK, Hussein G. Efficacy of 577 nm pro-yellow laser in the treatment of melasma: a prospective split-face study. J Cosmet Laser Ther. 2020;22:1-4. doi: 10.1080/14764172.2020. DOI: https://doi.org/10.1080/14764172.2020.1744661

Sarac G, Kapicioglu Y, Cenk H. An evaluation of the efficacy of a single‐session 577 nm pro‐yellow laser treatment in patients with postacne erythema and scarring. Dermatol Ther. 2021;34(1):e14611. doi: 10.1111/dth.14611. DOI: https://doi.org/10.1111/dth.14611

Deegan AJ, Wang RK. Microvascular imaging of the skin. Physics Med Biol. 2019;64(7):07TR1. doi: 10.1088/1361-6560/ab03f1. DOI: https://doi.org/10.1088/1361-6560/ab03f1

Al-Atta DM, Al-Samarraee MF, Fadhil AA, Kadhim ST, Alsarhan HW. Compliance with second visit of diabetes mellitus screening program and impact of dietary and exercise modification on glycemic control. Al-Rafidain J Med Sci. 2025;8(2):150-156. doi: 10.54133/ajms.v8i2.1929. DOI: https://doi.org/10.54133/ajms.v8i2.1929

Zhai Q, Cheng S, Liu R, Xie J, Han X, Yu Z. Meta‐analysis of the efficacy of intense pulsed light and pulsed‐dye laser therapy in the management of rosacea. J Cosmetic Dermatol. 2024;23(12):3821-3827. doi: 10.1111/jocd.16549. DOI: https://doi.org/10.1111/jocd.16549

Downloads

Published

2025-12-01

How to Cite

Hasan, E. F., Ahmed, M. H., & Hraiga, N. M. (2025). Evaluating the Clinical Outcomes of Using Pro-Yellow Laser for Steroid-Induced Rosacea: A Prospective Clinical Study . Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 9(2), 327–332. https://doi.org/10.54133/ajms.v9i2.2445

Issue

Section

Original article

Similar Articles

1 2 3 4 5 6 > >> 

You may also start an advanced similarity search for this article.